A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency

Sponsor
Pascoe Pharmazeutische Praeparate GmbH
Study ID
NCT06983847
Status
Recruiting
Apply to this trial

Conditions

  • Acute Disease
  • Chronic Disease
  • Deficiency, Vitamin C

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to learn more about the disease and the symptoms where the product will use and in which patient groups. Further on, it is interesting to know clinical pictures, the symptoms improve. Patients with acute or chronical disease with vitamin c deficiency could be involved. The main questions it aims to answer are: * how do the symptoms of the disease change * how is the tolerability

Key Dates

First listed
May 21, 2025
Start date
Jan 12, 2019
Status verified
May 2025
Primary completion
Jan 12, 2028
Completion
Nov 14, 2028

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Vit C deficiency in acute diseases
    Patients with vitamin C deficiency due to a acute underlying disease treated with Vitamin-C injektopas® 7.5 g
  • Arm: Vit C deficiency in chronic diseases
    Patients with vitamin C deficiency due to a chronic underlying disease treated with Vitamin-C injektopas® 7.5 g

Primary Outcome Measure

change in general and disease-specific symptoms [ Time Frame: therapy duration, an expected average of 3 weeks (for acute diseases) or 12 weeks (for chronic diseases) ]

Central Contacts

Related Studies